SJM
12
-4
XYL
27
-2
UHS
60
-2
EIX
54
-2
UNH
36
-2
KIM
51
-3
AZO
43
-5
HRL
30
-5
PVH
42
-2
TGNA
58
2
SLB
42
-4
DHR
64
-4
ORLY
40
-4
ECL
52
-2
MCHP
45
-4
TEL
72
-2
MU
56
-6
CMCSA
53
7
LH
48
-2
AME
66
-3
SJM
12
-4
XYL
27
-2
UHS
60
-2
EIX
54
-2
UNH
36
-2
KIM
51
-3
AZO
43
-5
HRL
30
-5
PVH
42
-2
TGNA
58
2
SLB
42
-4
DHR
64
-4
ORLY
40
-4
ECL
52
-2
MCHP
45
-4
TEL
72
-2
MU
56
-6
CMCSA
53
7
LH
48
-2
AME
66
-3
Financhill
Back

Vanguard Short-Term Tax-Exempt Bond ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
43

VTES
Vanguard Short-Term Tax-Exempt Bond ETF

Last Price:
$101.56
Seasonality Move:
1.31%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Sell
43
Vanguard Short-Term Tax-Exempt Bond ETF (VTES) is a Sell

Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?

  • The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.56. The Score for VTES is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • VTES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VTES Stock Price Chart

What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?

  • The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

VTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 13.26 Buy
Relative Strength Index (14 RSI): 53.37 Buy
Chaikin Money Flow: 66189 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.73 - 61.13) Sell
Bollinger Bands (100): (33.63 - 62.73) Buy

VTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.49 Buy
20-day SMA: 101.5 Buy
50-day SMA: 101.55 Buy
200-day SMA: 101.02 Buy
8-day EMA: 101.31 Buy
20-day EMA: 93.18 Buy
50-day EMA: 64.16 Buy
200-day EMA: 22.45 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):